His main area of research is evidence based pharmacotherapy among patients with metabolic / hormondreal disorders and patient with renal and cardiovascular diseases. In addition, he is one of the leading experts in systematic reviews and meta/network-meta analysis from the Asian region. To date he has published more three hundred research papers in ISI-cited journals with a cumulative impact factor of 450, H-index 33 and I10 index 105. He has authored various book chapters published by tier one publishers. Dr. Khan has joined UVAS in May 2018 as an Associate Professor at the Institute of Pharmaceutical Science and currently working as Director of the institute since April 2019.